Showing results (71-80 of 99) with videos related to
Sort By:
Pageof 10
Toxicologic Pathology|March 29, 2017
Inflammatory Cell Findings in the Female Rabbit Heart and Stress-associated Exacerbation with Handling and Procedures Used in Nonclinical StudiesRani S Sellers, Ingrid Pardo, George Hu, et al.Global Public Health|July 24, 2023
Economic and humanistic burden of HPV-related disease in Indonesia: A qualitative analysisMarisa Felsher, Didik Setiawan, Stefan Varga, et al.Journal of Alzheimer'S Disease : JAD|June 27, 2022
Prevalence of Depressive Symptoms in a Memory Clinic Cohort: A Retrospective StudyFlavia Loreto, Anna Fitzgerald, Mara Golemme, et al.Journal of Neurology|October 15, 2021
The impact of the UK COVID-19 pandemic on patient-reported health outcomes after stroke: a retrospective sequential comparisonHatice Ozkan, Gareth Ambler, Gargi Banerjee, et al.Future Oncology (London, England)|June 11, 2024
Clinical consensus on treatments for transplant-ineligible newly diagnosed multiple myeloma: double-blinded Delphi panelRafael Fonseca, Adriana Rossi, Rohan Medhekar, et al.BMJ Open|January 30, 2026
Stroke Investigation Group in North and Central London (SIGNAL): cohort profile of a prospective large-scale comprehensive stroke registryHatice Ozkan, Gareth Ambler, Philip S Nash, et al.Journal of Mammalogy|September 19, 2022
Evidence of a population of leaf-eared mice Phyllotis vaccarum above 6,000 m in the Andes and a survey of high-elevation mammalsScott J Steppan, Thomas Bowen, Max R Bangs, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 15, 2024
Alzheimer's disease heterogeneity revealed by neuroanatomical normative modelingFlavia Loreto, Serena Verdi, Seyed Mostafa Kia, et al.Journal of the American Association of Nurse Practitioners|December 19, 2025
Expert consensus on patient engagement strategies for improving patient activation and shared decision making in pulmonary arterial hypertensionJohn J Ryan, Melisa Wilson, Rajan Saggar, et al.The Journal of Prevention of Alzheimer'S Disease|February 14, 2026
Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotesRichard Perry, Christopher Kipps, Maria Eugenia Soto Martín, et al.Pageof 10